Conversations with Innovators: Joseph Connors, MD, on Targeted Therapy for Hodgkin Lymphoma
507 views · Published 4 September 2018 · 6:09 · Indexed 22 October 2026
Channel: American Society of Hematology · 2018 · Nonprofits & Activism
Dr. Conner discusses the Phase 3 Echelon-1 Study on targeted therapy for patients with Hodgkin Lymphoma. Visit http://www.hematology.org/Thehematologist for more videos, podcasts, and articles related to cutting-edge hematology research and practice.
More from this channel
-
1:52
Ron Reagan Accepts ASH Award - Stem Cell Research
-
4:25
Sen. Jim Talent's Work on Sickle Cell Disease Legislation
-
3:56
ASH and the Reagans Support Stem Cell Research
-
5:42
The American Society of Hematology Celebrates its 50th Anniversary
-
5:57
David Nathan Receives 2011 Wallace H. Coulter Award for Lifetime Achievement in Hematology
-
5:17
James George Receives 2012 Wallace H. Coulter Award for Lifetime Achievement in Hematology
-
2:21
Congress: Protect NIH funding
-
2:21
Act Now: Tell Congress to Stop Further Cuts to Research Funding